Once you finish using steroids, does simply stopping the medication return you to your original state? In this Anamed column, ...

The FDA previously approved FoundationOne CDx, which uses a tumor tissue sample, and FoundationOne Liquid CDx, which uses a ...

The approval makes the PARP inhibitor available earlier in the line of treatment for some patients with metastatic disease.

WELLINGTON, Oct 22 (Reuters) - New Zealand's High Court has struck down regulations banning new prescriptions of puberty ...

Long after successful radiotherapy for pineal germinoma, this patient developed pituitary insufficiency and later a rare metachronous CNS germ cell tumor.

Corporation, a biopharmaceutical company dedicated to advancing reproductive medicine, today announced the completion of ...

The randomised, multi-centre, placebo-controlled, double-blind trial screened over 750 women across fertility clinics in the ...

GLP-1 receptor agonists (so-called "weight-loss drugs") such as semaglutide, liraglutide, and tirzepatide have become widely ...

A cross-sectional study of 187 pregnant women in Taiwan found that self-reported symptoms such as tiredness and dizziness ...

1. FDA approves talazoparib with enzalutamide for metastatic androgen pathway modulation-naïve or -sensitive prostate cancer ...

‘Microneedle’ developed to ease burden of repeated hormone injections in infertility treatment ...

Neoadjuvant therapy with trastuzumab deruxtecan is of only “modest” benefit in patients with HER2-low, HR+ early-stage breast ...